PMGC Holdings (ELAB) Exchange Rate Effect (2022 - 2026)
PMGC Holdings' (ELAB) quarterly Exchange Rate Effect came in at $2339.0 in Q1 2026, up 598.72% year-over-year from $334.75 in Q1 2025, and up 464.98% quarter-over-quarter from $414.0 in Q4 2025.
Powered by 
Analysis
PMGC Holdings (ELAB) Exchange Rate Effect (2022 - 2026) Analysis & Trends
PMGC Holdings has disclosed Exchange Rate Effect across 5 years of filings, most recently posting $2339.0 for Q1 2026.
- In Q1 2026, Exchange Rate Effect rose 598.72% year-over-year to $2339.0; the TTM figure through Jun 2026 stood at $2916.0 (up 234.13% YoY), while the FY2025 annual figure was $177.0, up 107.52% from the prior year.
- Exchange Rate Effect came in at $2339.0 for Q1 2026 at PMGC Holdings, up from $414.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $1.1 million in Q4 2022 to a low of -$1587.0 in Q4 2024.
- Average Exchange Rate Effect over 5 years is $78850.8, with a median of $152.0 recorded in 2023.
- Year-over-year, Exchange Rate Effect tumbled 2237.5% in 2024 and soared 598.72% in 2026.
- Over 5 years, Exchange Rate Effect stood at $1.1 million in 2022, then tumbled by 99.97% to $342.0 in 2023, then slumped by 564.04% to -$1587.0 in 2024, then surged by 126.09% to $414.0 in 2025, then soared by 464.98% to $2339.0 in 2026.
- Per Business Quant data, the three most recent Exchange Rate Effect figures were $2339.0 in Q1 2026, $414.0 in Q4 2025, and $163.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.40 Bn | 192.42 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 180.38 Bn | 177.20 Bn | 6.22 Bn | -19.00 Mn |
| 3 | Vertex Pharmaceuticals | 131.28 Bn | 123.43 Bn | 2.84 Bn | -3.70 Mn |
| 4 | Regeneron Pharmaceuticals | 81.73 Bn | 73.73 Bn | 3.93 Bn | -300,000.00 |
| 5 | Argenx Se | 60.28 Bn | 55.09 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.02 Bn | 48.88 Bn | 52.00 Mn | -2.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.28 Bn | 29.97 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Biogen | 31.81 Bn | 30.52 Bn | 1.96 Bn | -3.40 Mn |
| 9 | Roivant Sciences | 29.02 Bn | 29.02 Bn | 1.16 Mn | 315,000.00 |
| 10 | PMGC Holdings | 2.29 Mn | -16.50 Mn | 385,691.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 2,339.00 |
| Dec 31, 2025 | 414.00 |
| Sep 30, 2025 | 163.00 |
| Jun 30, 2025 | 69.00 |
| Mar 31, 2025 | -469.00 |
| Dec 31, 2024 | -1,587.00 |
| Sep 30, 2024 | -187.00 |
| Jun 30, 2024 | -754.00 |
| Mar 31, 2024 | 174.00 |
| Dec 31, 2023 | 342.00 |
| Sep 30, 2023 | -8.00 |
| Jun 30, 2023 | 587.00 |
| Mar 31, 2023 | 141.00 |
| Dec 31, 2022 | 1.10 Mn |